68Ga-RM26

DRUG2 trials

Sponsors

Peking Union Medical College Hospital

Conditions

Brain TumorBreast CancerGliomaPET/CT ImagingProstate Cancer

Early Phase 1

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

RecruitingNCT05549024

Peking Union Medical College HospitalBrain Tumor, Breast Cancer, PET/CT Imaging +1

Start: 2022-08-16End: 2026-12-31Target: 90Updated: 2024-07-05

68Ga-NOTA-RM26 PET/CT in Glioma Patients

RecruitingNCT06412952

Peking Union Medical College HospitalGlioma

Start: 2022-10-01End: 2024-05-31Target: 30Updated: 2024-05-14

Related Papers

Abstract P2-07-14: Head-to-head comparison of the dual-targeting tracer [68Ga]Ga-RM26-RGD and [18F]FDG for PET imaging of breast cancer

Clinical Cancer Research2025-06-13

<sup>68</sup>Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study.

2025-01-173 citations